Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin

Takeshi Yokoyama, F. Yamasaki, K. Yamashita, M. Manabe, K. Suwa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: In planning surgery, a low-dose aspirin regimen for prevention of thrombotic events is often discontinued in order to avoid the risk of excessive bleeding during surgery. However, this procedure increases the risk from adverse thrombotic events. We propose a different method, which may normalize the prolonged bleeding time caused by low-dose aspirin. We verified the effectiveness of this method in healthy volunteers. Methods: Volunteers with bleeding time prolonged by taking 81 mg of aspirin a day for a period of 1 week were randomly divided into two groups. The test group of 18 volunteers received a dose of 660 mg of aspirin, while the control group of 16 received placebo. Bleeding time and maximum platelet activity were then evaluated. Results: Before 660 mg of aspirin or placebo, bleeding time was prolonged: in the aspirin group from 3.1 ± 0.7 to 6.1 ± 1.4 min (n=18), and in the placebo group from 2.9 ± 0.9 to 6.1 ± 1.5 min (n=16). This prolongation was significant in both groups at the P<0.01 level. In the test group, bleeding time was shortened to 4.5 ± 1.3 min (P<0.01), which is in the normal range, while it remained prolonged in the control group (6.0 ± 1.2 min). Platelet activity, on the other hand, was suppressed in both groups. Conclusion: We conclude that 660 mg of aspirin effectively shortens the bleeding time prolonged by daily low-dose (81 mg) aspirin.

Original languageEnglish
Pages (from-to)1226-1230
Number of pages5
JournalActa Anaesthesiologica Scandinavica
Volume52
Issue number9
DOIs
Publication statusPublished - Oct 2008
Externally publishedYes

Fingerprint

Bleeding Time
Aspirin
Placebos
Volunteers
Blood Platelets
Control Groups
Healthy Volunteers
Reference Values
Hemorrhage

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin. / Yokoyama, Takeshi; Yamasaki, F.; Yamashita, K.; Manabe, M.; Suwa, K.

In: Acta Anaesthesiologica Scandinavica, Vol. 52, No. 9, 10.2008, p. 1226-1230.

Research output: Contribution to journalArticle

Yokoyama, Takeshi ; Yamasaki, F. ; Yamashita, K. ; Manabe, M. ; Suwa, K. / Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin. In: Acta Anaesthesiologica Scandinavica. 2008 ; Vol. 52, No. 9. pp. 1226-1230.
@article{f6811ace514a4806961df80bf622ceed,
title = "Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin",
abstract = "Background: In planning surgery, a low-dose aspirin regimen for prevention of thrombotic events is often discontinued in order to avoid the risk of excessive bleeding during surgery. However, this procedure increases the risk from adverse thrombotic events. We propose a different method, which may normalize the prolonged bleeding time caused by low-dose aspirin. We verified the effectiveness of this method in healthy volunteers. Methods: Volunteers with bleeding time prolonged by taking 81 mg of aspirin a day for a period of 1 week were randomly divided into two groups. The test group of 18 volunteers received a dose of 660 mg of aspirin, while the control group of 16 received placebo. Bleeding time and maximum platelet activity were then evaluated. Results: Before 660 mg of aspirin or placebo, bleeding time was prolonged: in the aspirin group from 3.1 ± 0.7 to 6.1 ± 1.4 min (n=18), and in the placebo group from 2.9 ± 0.9 to 6.1 ± 1.5 min (n=16). This prolongation was significant in both groups at the P<0.01 level. In the test group, bleeding time was shortened to 4.5 ± 1.3 min (P<0.01), which is in the normal range, while it remained prolonged in the control group (6.0 ± 1.2 min). Platelet activity, on the other hand, was suppressed in both groups. Conclusion: We conclude that 660 mg of aspirin effectively shortens the bleeding time prolonged by daily low-dose (81 mg) aspirin.",
author = "Takeshi Yokoyama and F. Yamasaki and K. Yamashita and M. Manabe and K. Suwa",
year = "2008",
month = "10",
doi = "10.1111/j.1399-6576.2008.01766.x",
language = "English",
volume = "52",
pages = "1226--1230",
journal = "Acta Anaesthesiologica Scandinavica",
issn = "0001-5172",
publisher = "Blackwell Munksgaard",
number = "9",

}

TY - JOUR

T1 - Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin

AU - Yokoyama, Takeshi

AU - Yamasaki, F.

AU - Yamashita, K.

AU - Manabe, M.

AU - Suwa, K.

PY - 2008/10

Y1 - 2008/10

N2 - Background: In planning surgery, a low-dose aspirin regimen for prevention of thrombotic events is often discontinued in order to avoid the risk of excessive bleeding during surgery. However, this procedure increases the risk from adverse thrombotic events. We propose a different method, which may normalize the prolonged bleeding time caused by low-dose aspirin. We verified the effectiveness of this method in healthy volunteers. Methods: Volunteers with bleeding time prolonged by taking 81 mg of aspirin a day for a period of 1 week were randomly divided into two groups. The test group of 18 volunteers received a dose of 660 mg of aspirin, while the control group of 16 received placebo. Bleeding time and maximum platelet activity were then evaluated. Results: Before 660 mg of aspirin or placebo, bleeding time was prolonged: in the aspirin group from 3.1 ± 0.7 to 6.1 ± 1.4 min (n=18), and in the placebo group from 2.9 ± 0.9 to 6.1 ± 1.5 min (n=16). This prolongation was significant in both groups at the P<0.01 level. In the test group, bleeding time was shortened to 4.5 ± 1.3 min (P<0.01), which is in the normal range, while it remained prolonged in the control group (6.0 ± 1.2 min). Platelet activity, on the other hand, was suppressed in both groups. Conclusion: We conclude that 660 mg of aspirin effectively shortens the bleeding time prolonged by daily low-dose (81 mg) aspirin.

AB - Background: In planning surgery, a low-dose aspirin regimen for prevention of thrombotic events is often discontinued in order to avoid the risk of excessive bleeding during surgery. However, this procedure increases the risk from adverse thrombotic events. We propose a different method, which may normalize the prolonged bleeding time caused by low-dose aspirin. We verified the effectiveness of this method in healthy volunteers. Methods: Volunteers with bleeding time prolonged by taking 81 mg of aspirin a day for a period of 1 week were randomly divided into two groups. The test group of 18 volunteers received a dose of 660 mg of aspirin, while the control group of 16 received placebo. Bleeding time and maximum platelet activity were then evaluated. Results: Before 660 mg of aspirin or placebo, bleeding time was prolonged: in the aspirin group from 3.1 ± 0.7 to 6.1 ± 1.4 min (n=18), and in the placebo group from 2.9 ± 0.9 to 6.1 ± 1.5 min (n=16). This prolongation was significant in both groups at the P<0.01 level. In the test group, bleeding time was shortened to 4.5 ± 1.3 min (P<0.01), which is in the normal range, while it remained prolonged in the control group (6.0 ± 1.2 min). Platelet activity, on the other hand, was suppressed in both groups. Conclusion: We conclude that 660 mg of aspirin effectively shortens the bleeding time prolonged by daily low-dose (81 mg) aspirin.

UR - http://www.scopus.com/inward/record.url?scp=51749100060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749100060&partnerID=8YFLogxK

U2 - 10.1111/j.1399-6576.2008.01766.x

DO - 10.1111/j.1399-6576.2008.01766.x

M3 - Article

C2 - 18823461

AN - SCOPUS:51749100060

VL - 52

SP - 1226

EP - 1230

JO - Acta Anaesthesiologica Scandinavica

JF - Acta Anaesthesiologica Scandinavica

SN - 0001-5172

IS - 9

ER -